20.74
+0.87(+4.38%)
Currency In USD
Address
490 Arsenal Way
Watertown, MA 02472
United States of America
Phone
N/A
Website
Sector
Healthcare
Industry
Biotechnology
Employees
51
First IPO Date
N/A
| Name | Title | Pay | Year Born |
| Dr. Alise S. Reicin M.D., Ph.D. | President, Chief Executive Officer, Secretary & Director | 1.01M | 1961 |
| Dr. Timothy A. Springer M.B.A., Ph.D. | Co-Founder & Independent Director | 24,000 | 1949 |
| Mr. Daniel Lochner M.B.A. | Chief Financial Officer | 625,975 | 1983 |
| Dr. Marcella Kuhlman Ruddy M.D., M.S. | Chief Medical Officer | 700,858 | 1964 |
| Dr. Peter McNamara Ph.D. | Chief Scientific Officer | 0 | 1972 |
| John Diener | Senior Vice President of Antibody Engineering & Protein Sciences | 0 | N/A |
| Dr. Marc Schwabish Ph.D. | Chief Business Officer | 0 | 1982 |
| Mr. Barry Rubenstein M.S. | Senior Vice President of People & Culture | 0 | N/A |
| Mr. Anthony Muslin M.D. | Chief Development Officer | 0 | N/A |
Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts.